France - Healthcare, Regulatory and Reimbursement Landscape

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,995	171 Pages	GlobalData	June, 2021	GBDT16692881

Best Price Guarantee
Price	from $1,995
Length	171 Pages
Publisher	GlobalData
Published Date	June, 2021
SKU	GBDT16692881

France - Healthcare, Regulatory and Reimbursement Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report, France - Healthcare, Regulatory and Reimbursement Landscape. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in France. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

France is the second largest pharmaceutical and medical device market, in terms of value, in Europe after Germany. The French pharmaceutical market increased from €53.69B in 2015 to €60.05B in 2019 at a Compound Annual Growth Rate (CAGR) of 2.84%. In terms of US Dollars, the market increased from $59.54B in 2013 to $67.25B in 2020 at a CAGR of 3.09%. It is forecast to reach about $82.02B in 2025. The changing demographics, chronic and lifestyle diseases, incentives for innovation, universal health coverage, and early access to innovative medicines are the main factors driving the growth of the French pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in France, and includes -

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: Bayer, Pfizer, Sanofi, Viatris, and Servier
Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Roche Diagnostics, EssilorLuxottica, and Air Liquide
An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure
An overview of the opportunities for and challenges to growth in the French healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

Develop business strategies by understanding the trends shaping and driving France’s healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact France’s healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

1. Table of Contents: 1.1 List of Figures; 1.2 List of Tables
2. Executive Summary: 2.1 Executive Summary; 2.2 Key Highlights - Facts about the French Healthcare Market; 2.3 Key Highlights: Healthcare Startups in France; 2.4 Key Events: French Healthcare Timeline, 2015-2021; 2.5 Key Events: French Pharmaceutical Market; 2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020; 2.7 Key Events: Mergers and Acquisitions; 2.8 Country Profile, France, 2020
3. Overview of Pharmaceutical Market: 3.1 Pharmaceutical Market - Overview; 3.2 Pharmaceutical Market - Exports; 3.3 Pharmaceutical Market - Imports; 3.4 Pharmaceutical Market - Supply Channels, France; 3.5 Pharmaceutical Market - Market Segments; 3.6 Major Therapeutic Areas, France; 3.7 COVID-19 Epidemiology, France; 3.8 COVID-19 Impact and Developments in the Healthcare Market, France; 3.9 COVID-19 Clinical Trials Landscape, France; 3.10 Pharmaceutical Market - Major Players
4. Overview of Medical Devices Market: 4.1 Medical Device Market - Overview; 4.2 Medical Devices Market - Major Players
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers: 5.1 Drivers; 5.2 Barriers
6. Deal Analysis: 6.1 Deal Analysis: Pharmaceutical Market, France, 2020-2021; 6.2 Deal Analysis: Medical Device Market, France, 2020-2021
7. HealthTech Landscape: 7.1 HealthTech Landscape, France; 7.2 HealthTech Deals Landscape, France; 7.3 Key HealthTech Deals, France; 7.4 Adoption of Technology in Healthcare, France; 7.5 Key Developments: HealthTech Against COVID-19 Crisis, France; 7.6 Regulatory Scenario Covering Use of Technology in Healthcare, France; 7.7 HealthTech Landscape: Benefits and Risks, France
8. Market Access: 8.1 Overview of Healthcare System, France; 8.2 Reimbursement of Medicinal Products, France; 8.3 Reimbursement of Medical Devices, France; 8.4 Overview of Insurance Providers, France; 8.5 Healthcare Spending and Medicine Price Index, France; 8.6 Pricing Policies, France; 8.7 Regulatory Landscape, France; 8.7.1 Overview of Regulatory Agencies; 8.7.2 Marketing Authorization for Pharmaceutical Products, France; 8.7.3 Marketing Authorization for Medical Devices, France; 8.7.4 Intellectual Property Rights, Patent, France; 8.7.5 Intellectual Property Rights, Trademark, France; 8.7.6 Clinical Trial Regulation, France; 8.7.7 Pharmaceutical Clinical Trials Landscape, France; 8.7.8 Medical Devices Clinical Trials Landscape, France; 8.7.9 Pharmaceutical Export and Import, France; 8.7.10 Pharmaceutical Advertisement Regulations, France; 8.7.11 Pharmaceutical Establishment Regulations, France; 8.6.12 Pharmacy Regulations, France; 8.7.13 Labeling and Packaging Regulations, France
9. Country Healthcare Landscape: 9.1 French Healthcare Policy Highlights; 9.2 Healthcare Facilities, France; 9.3 Healthcare Parameters, France; 9.4 Life Expectancy and Immunization Rate, France; 9.5 Environmental Health, France; 9.6 Healthcare Personnel, France; 9.7 Disease Burden, France; 9.8 Healthcare Expenditure, France
10 Trade Associations, France
11 Trade Fairs, France
12 Opportunities and Challenges
13 Appendix: 13.1 Research Methodology; 13.1.1 Coverage; 13.1.2 Secondary Research; 13.1.3 Forecasts; 13.2 Bibliography; 13.3 About GlobalData; 13.4 Contact Us; 13.5 Disclaimer
List of Tables: Table 1: Approved Biosimilars, EU, 2020-2021; Table 2: Top Five Therapeutic Areas by Annual Revenue (%), France, 2019; Table 3: COVID-19 Indicators (Number of Cases), Global and France, 2020-2021; Table 4: COVID-19-Related Travel Restrictions, France, 2020-2021; Table 5: COVID-19 Vaccines Authorized, France, 2020-2021; Table 6: COVID-19 Vaccines Under Evaluation, France, 2021; Table 7: COVID-19 IVD Products (June ‘20- June ‘21), France, 2020-2021; Table 8: Medical Device Market, France, Major Segments ($B), 2020; Table 9: General Surgery Market, France, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 10: Cardiovascular Devices Market, France, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 11: Wound Care Management Market, France, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 12: Orthopedic Devices Market, France, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 13: Anesthesia and Respiratory Devices Market, France, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 14: Actual Clinical Benefit Levels, France, 2021; Table 15: Clinical Added Value Levels, France, 2021; Table 16: Reimbursement Rates for Medical Procedures and Services Covered by Health Insurance Schemes, France, 2021; Table 17: Wholesalers-distributors Margin, France, 2020; Table 18: Patent Fees, France, 2021; Table 19: Trademark Fees, France, 2021; Table 20: Outer Packaging of Solid Oral Forms, France, 2021; Table 21: Recommendations Specific to Small Packaging, France, 2021; Table 22: Primary Packaging of Solid Oral Forms, France, 2021; Table 23: Recommendations Specific to Small Blister Packs, France, 2021
List of Figures: Figure 1: Pharmaceutical Market, France, Revenue ($B and €B), 2013-2020; Figure 2: Medical Devices Market, France, Revenue ($B), 2015-2020; Figure 3: Healthcare Startups in France, 2021; Figure 4: Number of Deals (2019-2020); Figure 5: 2019-2020 Deal Overview by Region; Figure 6: Country Profile, France, 2020; Figure 7: Pharmaceutical Market, France, Revenue ($B and €B), 2013-2020; Figure 8: Pharmaceutical Market, France, Revenue Forecast ($B and €B), 2021-2025; Figure 9: Pharmaceutical Exports ($B), France, 2013-2020; Figure 10: Top Export Partners, France, 2020; Figure 11: Pharmaceutical Imports ($B), France, 2013-2020; Figure 12: Top Import Partners, France, 2020; Figure 13: Pharmaceutical Supply Channel, France, 2019; Figure 14: % Share of Generics by Value, France, 2019; Figure 15: % Share of Generics by Volume, France, 2019; Figure 16: Marketing Authorizations (MA) for Generic Medicines, France, 2015-2019; Figure 17: Health Competitiveness Clusters, France, 2021; Figure 18: OTC Market, France, Revenue ($B), 2013-2020; Figure 19: OTC Market by Drug Category, France, Revenue ($M), 2020; Figure 20: Top Five Therapeutic Areas by Annual Revenue (%), France, 2019; Figure 21: COVID-19 Cases, France, 2020-2021; Figure 22: COVID-19 Deaths, France, 2020-2021; Figure 23: COVID-19 Fiscal Stimulus Timeline, France, 2020-2021; Figure 24: Vaccine Doses Administered per 1,000 People, France, 2021; Figure 25: COVID-19 Clinical Trials Count by Phase, France, 2020-2021; Figure 26: COVID-19 Clinical Trials Count by Trial Status, France, 2020-2021; Figure 27: Top Five COVID-19 Clinical Trials Sponsors by Trial Count, France, 2020-2021; Figure 28: Medical Devices Market, France, Revenue ($B), 2015-2020; Figure 29: Medical Devices Market, France, Revenue Forecast ($B), 2021-2025; Figure 30: Medical Device Market, France, Major Segments (%), 2020; Figure 31: General Surgery Market, France, Revenue ($B), 2017-2025; Figure 32: General Surgery Market, France, Market Share of Major Players (%), 2020; Figure 33: Cardiovascular Devices Market, France, Revenue ($B), 2017-2025; Figure 34: Cardiovascular Devices Market, France, Market Share of Major Players (%), 2020; Figure 35: Wound Care Management Market, France, Revenue ($B), 2017-2025; Figure 36: Wound Care Management Market, France, Market Share of Major Players (%), 2020; Figure 37: Orthopedic Devices Market, France, Revenue ($B), 2017-2025; Figure 38: Orthopedic Devices Market, France, Market Share of Major Players (%), 2020; Figure 39: Anesthesia and Respiratory Devices Market, France, Revenue ($B), 2017-2025; Figure 40: Anesthesia and Respiratory Devices Market, France, Market Share of Major Players (%), 2020; Figure 41: Diagnostics Market, France, Revenue ($B), 2015-2020; Figure 42: Diagnostics Market, France, Revenue Forecast ($B), 2021-2025; Figure 43: Medical Devices Market, Revenue ($B) of Major Companies, France, 2020; Figure 44: Deal Value and Deal Count, Pharmaceutical Market, France, 2020-2021; Figure 45: Deal Value and Deal Count Sub-types, Pharmaceutical Market, France, 2020-2021; Figure 46: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, France, 2020-2021; Figure 47: Top Five Therapy Areas by Deal Value and Deal Count, Pharmaceutical Market, France, 2020-2021; Figure 48: M&A Deals by Therapy Area, Pharmaceutical Market, France, 2020-2021 (by Value ($M) and by Number); Figure 49: VC Deals by Therapy Area, Pharmaceutical Market, France, 2020-2021 (by Value ($M) and by Number); Figure 50: PE Deals by Therapy Area, Pharmaceutical Market, France, 2020-2021 (by Value ($M) and by Number); Figure 51: Medical Devices Market Deals by Deal Value ($M), France, 2020-2021; Figure 52: Medical Devices Market Deals by Deal Count, France, 2020-2021; Figure 53: Medical Devices Market Deals Share by Deal Value, France, 2020-2021; Figure 54: Medical Devices Market Deals Share by Deal Count, France, 2020-2021; Figure 55: Top Five Therapy Area by Deal Value ($M), Medical Devices Market, France, 2020-2021; Figure 56: Top Five Therapy Area by Deal Count, Medical Devices Market, France, 2020-2021; Figure 57: M&A Deals by Therapy Area, Medical Devices Market, France, 2020-2021 (by Value ($M) and by Number); Figure 58: VC Deals by Therapy Area, Medical Devices Market, France, 2020-2021 (by Value ($M) and by Number); Figure 59: Number of Products in Development and Marketed by French HealthTech and Purposes, France, 2020; Figure 60: Adoption of eHealth Technologies, France, 2020; Figure 61: Deal Value ($B), HealthTech, France, 2020-2021; Figure 62: Deal Count (No. of Deals), HealthTech, France, 2020-2021; Figure 63: Type of Products Developed by HealthTech Companies Against COVID-19, France, 2020; Figure 64: Health Innovation Coalition Projects, France, 2020; Figure 65: Organization of the Health System, France, 2020; Figure 66: Reimbursement of Medicinal Products, France, 2020; Figure 67: Reimbursement of Medical Devices, France, 2021